Asymchem Laboratories: 2024 First Quarter Report
Apr 25 12:00 ET
Gloria Ying: Announcement on the repurchase ratio of the company's shares reaching 2% and the progress of the repurchase
Apr 25 12:00 ET
Gloria Ying: 002821 Gloria Ind Investor Relations Management Information 20240422
Apr 22 06:07 ET
Gloria Ying: Announcement on holding the 2023 Online Results Briefing
Apr 17 12:00 ET
Gloria Ying: Announcement on the repurchase ratio of the company's shares reaching 1% and the progress of the repurchase
Apr 10 12:00 ET
Gloria Ying: The 2020 Restricted Stock Incentive Plan granted an indicative announcement for the first time to lift restrictions on sale and circulation for the third time
Apr 8 12:00 ET
Gloria Ying: Announcement on the progress of the repurchase
Apr 2 12:00 ET
Gloria Ying: March 28, 2024 Gloria Ind Specific Object Research Record Form
Mar 28 12:49 ET
Gloria Ying: March 28, 2024 Gloria Ind Object Research Demonstration Material
Mar 28 12:47 ET
Gloria Ying: 2023 Board Work Report
Mar 28 12:00 ET
Gloria Ying: 2023 Independent Director Debriefing Report (Sun Xuejiao)
Mar 28 12:00 ET
Gloria Ying: Internal Control Audit Report
Mar 28 12:00 ET
Gloria Ying: Announcement on Launching Foreign Exchange Derivatives Trading Business
Mar 28 12:00 ET
Gloria Ying: First Venture Securities Underwriting and Sponsorship Co., Ltd. inspection opinions on the storage and use of funds raised by Gloria Ying Pharmaceutical Group (Tianjin) Co., Ltd. in 2023
Mar 28 12:00 ET
Gloria Ying: Special instructions on the use of funds raised in the year
Mar 28 12:00 ET
Gloria Ying: 2023 Annual Audit Report
Mar 28 12:00 ET
Gloria Ying: Announcement on the 2024 Remuneration Plan for Directors, Supervisors, and Senior Managers
Mar 28 12:00 ET
Gloria Ying: Announcement on renewing the Company's 2024 Audit Institution
Mar 28 12:00 ET
Gloria Ying: 2023 Independent Director Debriefing Report (Zhang Kun)
Mar 28 12:00 ET
Gloria Ying: Announcement of Board Resolutions
Mar 28 12:00 ET
No Data
No Data